Biotech entity
pharma is the sole category represented across all 1 tracked stories. ALS (Amyotrophic Lateral Sclerosis) is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. We currently track 1 Biotech story that mention Brittany Johnson, all published on August 7, 2026.
Last mentioned: Aug 7, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
pharma is the sole category represented across all 1 tracked stories. ALS (Amyotrophic Lateral Sclerosis) is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. We currently track 1 Biotech story that mention Brittany Johnson, all published on August 7, 2026. Each carries 2 original sources on average.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 7 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Brittany Johnson. Shared-story counts are live from our verified record — not editorial picks.
The devastating speed of Chris Johnson’s sporadic ALS—from an elite athlete to eye-controlled communication in a year—exposes the profound unmet need in neurodegenerative drug development. With current therapies offering only months of survival benefit, the biopharma sector faces immense pressure to deliver disease-modifying treatments.
Source: abcnews.com · thegrio.com
Brittany Johnson is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
